Currently, numerous tests are available for the assessment and triage of patients with stable ischaemic heart disease. National societies in the USA have collaborated to develop appropriate use criteria to give guidance to clinicians about the evidence-based use of these tests.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Go, A. S. et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation http://dx.doi.org/10.1161/01.cir.0000441139.02102.80.
Heidenreich, P. A. et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 123, 933–944 (2011).
Wolk, M. J. et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease. J. Am. Coll. Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.11.009.
Hendel, R. C. et al. Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force. J. Am. Coll. Cardiol. 61, 1305–1317 (2013).
US National Library of Medicine. ClinicalTrials.gov[online], (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Bansilal, S., Fayad, Z. Appropriate testing for stable ischaemic heart disease. Nat Rev Cardiol 11, 137–138 (2014). https://doi.org/10.1038/nrcardio.2014.5
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2014.5
